Discovery of a novel TLR2 signaling inhibitor with anti-viral activity.
Discovery of a novel TLR2 signaling inhibitor with anti-viral activity.
复制标题
DOI:
10.1016/j.antiviral.2010.06.011
复制
发表时间:
2010-09
影响因子:
7.6
通讯作者:
Finberg, Robert W.
中科院分区:
文献类型:
--
作者:
Zhou, Shenghua;Cerny, Anna M.;Bowen, Glennice;Chan, Melvin;Knipe, David M.;Kurt-Jones, Evelyn A.;Finberg, Robert W.
Blockade of Toll-like receptor (TLR)-mediated inflammatory responses represents a new approach in the development of anti-inflammation therapeutics. In the present study, we have screened for TLR2-mediated inflammation inhibitors from a small molecule compound library using a sensitive cell line stably expressing TLR2, CD14, and an NF-κB-driven-luciferase reporter gene. Lymphocytic choriomeningitis virus (LCMV) was used as a virus model. This arenavirus activates a TLR2/CD14-dependent NF-κB signaling pathway. We have identified 10 potential anti-inflammatory compounds out of 101306 compounds. We further evaluated 1 of these positive compounds, E567. We demonstrated that compound E567 efficiently inhibits both LCMV and Herpes simplex virus 1 (HSV-1) induced cytokine responses in both human and mouse cell cultures. We also demonstrated that E567 inhibits cytokine responses in the mouse. Remarkably, E567 is also capable of inhibiting LCMV replication in mice. This is a new model for developing drugs for use in treating viral illnesses.
登录
查看更多内容
影响因子:
6.7
作者:
Le Goffic, Ronan;Balloy, Viviane;Lagranderie, Micheline;Alexopoulou, Lena;Escriou, Nicolas;Flavell, Richard;Chignard, Michel;Si-Tahar, Mustapha
通讯作者:
Si-Tahar, Mustapha
影响因子:
3.7
作者:
Gowen BB;Smee DF;Wong MH;Hall JO;Jung KH;Bailey KW;Stevens JR;Furuta Y;Morrey JD
通讯作者:
Morrey JD
影响因子:
7.3
作者:
Seyberth, T;Voss, S;Jung, G
通讯作者:
Jung, G
影响因子:
5.4
作者:
Zhou, SH;Kurt-Jones, EA;Finberg, RW
通讯作者:
Finberg, RW
影响因子:
5.4
作者:
Murawski, Matthew R.;Bowen, Glennice N.;Finberg, Robert W.
通讯作者:
Finberg, Robert W.